Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects

NCT05823779 is registered in ClinicalTrials.gov with Global Research Institute as lead sponsor.

NCT NCT05823779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05823779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects
Lead sponsor
Global Research Institute
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2022
Completion date
April 1, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes simplex 1, herpes simplex 2, hiv disease